AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE PHASE 1, CLINICAL STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF TETANUS VACCINE OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS UNDER FASTING CONDITION
Latest Information Update: 05 Sep 2024
At a glance
- Drugs Tetanus vaccine Zydus Lifesciences (Primary)
- Indications Tetanus
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 19 Feb 2014 New trial record